Andrew has 17 years of biotechnology experience including 12 years of biomedical laboratory research experience, and also served as a patent examiner in the bioinformatics art unit at the U.S. Patent and Trademark Office. He co-authored five biomedical research articles published in peer-reviewed journals, and is first inventor on over 35 pending patents.

His expertise includes the areas of gene discovery, gene cloning, in vivo genetic modification, purification of DNA, RNA and proteins, bioassays, protein characterization, antibody synthesis and purification, immunoassays, animal models of disease, epidemiology, clinical trial design, and bioinformatics.

Andrew holds the following degrees:

• Ph.D. - Cellular & Molecular Medicine - Johns Hopkins University

• M.S. - Biology - Rensselaer Polytechnic Institute

• B.S. - Biology - Rensselaer Polytechnic Institute

Andrew discovered and cloned a human colon cancer associated gene, CCCAP, and characterized its encoded protein as part of his doctoral work. Through a postdoctoral fellowship at the Johns Hopkins University School of Medicine he used forced gene expression to study tumorigenesis inhibition in rodents. And in a second postdoctoral fellowship at the Johns Hopkins University Bloomberg School of Public Health he documented gene expression profiles and oxidative radical production during genesis and activation of macrophagic white blood cells.

Andrew graduated Summa Cum Laude with B.S. and M.S. degrees in four years from Rensselaer Polytechnic Institute where he achieved the highest academic record in his graduating class. He received many awards including the Howard Hughes Medical Institute Student Research Grant, the Rensselaer Academic Citation Award, the J. Erik Jonsson Prize, and the Roland Walker Prize.

Phone: 267.880.1720, ext.126
Fax: 267.880.1721
Email: akenedy@techpats.com